Alexanderson RE

Language: Spanish
References: 15
Page: 9-12
PDF size: 52.35 Kb.

ABSTRACT

The mean goal in the evaluation of a patient with coronary artery disease is the identification of patients at high risk to develop major cardiac events, including mortality. Ischemic patients can be stratified using non-invasive and invasive methods. Invasive procedures have some disadvantages,especially in follow-up studies. Nuclear Cardiology procedures, such as perfusion studies performed with thallium or 99mTc labeled agents (sestamibi, tetrofosmin), radioventriculography for right and left ventricle function evaluation and Gated SPECT are considered the best non-invasive procedures not only for the diagnosis of myocardial ischemia but for risk stratification. These techniques can identify the group of patients at high risk to develop major cardiovascular events, constituted by patients with perfusion abnormalities, specially during stress and systolic left ventricle dysfunction.

REFERENCES

1. Alexanderson E: Cardiología Nuclear y Cardiopatía Isquémica. En: Vargas Barrón J. editor. Diagnóstico de la Cardiopatía Isquémica. México, Ed. Panamericana, 1999.

2. Soman P, Parsons A, Lahiri N, Lahiri A: The prognostic value of a normal Tc-99m Sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999; 6: 252-6.

3. Kamal AM, Fattah AA, Pancholy S, Aksut S, Cave V, Heo J, et al: Prognostic value of adenosineg single-photon computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994; 1: 254-61.

4. Iskandrian AS, Heo J, Nguyen T, Beer SG, Cave G, Ogilby D, et al: Assessment of coronary artery disease using SPECT with thallium 201 during adenosine induced coronary hyperemia. Am J Cardiol 1991; 67: 1190-4.

5. Coyne EP, Belvedere DA, Vande-Streek PR, Weiland FL, Evans RB, Spaccavento LJ: Thallium 201 scintigraphy after intravenous adenosine infusion compared with exercise thallium testing in the prognosis of coronary artery disease. J Am Coll Cardiol 1991; 17: 1289-94.

6. Alexanderson E, Gomezleón A, García LJ: Detección de isquemia miocárdica mediante la administración de adenosina y técnica SPECT. Experiencia inicial en México. Arch Inst Cardiol Mex 1999; 69: 546-53.

7. Steingart RM, Hodnett P, Musso J Feurman M: Exercise myocardial perfusion imaging in elderly patients. J Nucl Cardiol 2002; 9: 573-80.

8. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al: Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion SPECT. J Am Coll Cardiol 1995; 26: 639-47.

9. Brown KA, Rowen M: Prognostic value of abnormal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993; 71: 865-7.

10. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-6.

11. Alexanderson E, Kiat H, Maciel S: Effects of ischemic preconditioning on myocardial infarct extent:evaluation using myocardial perfusion SPECT (abst). J Nucl Cardiol 1999; 6: S3.

12. Germano G, Berman DS: Clinical Gated Cardiac SPECT. New York, Futura Publishing Company. 1999.

13. Alexanderson E, Marquez M, Roldán F: Valoración de la función ventricular mediante cardiología nuclear. Parte II: Aplicaciones clínicas. Arch Inst Cardiol Mex 2000; 70: 499-512.

14. Villari B, Betocchi S, Pace L, Piscione F, Russolillo E, Ciarmiello A, et al: Assessment of left ventricular diastolic function : comparison of contrast ventriculography and equillibrium radionuclide angiography. J Nucl Med 1991; 32: 1849-53.

15. Sharir T, Germano G, Kavanagh P Lai S, Cohen I, Berman D, et al: Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-42.